The Covid-19 Vaccine-Development Multiverse. Reply.
作者信息
Heaton Penny M
机构信息
Bill and Melinda Gates Medical Research Institute, Cambridge, MA
出版信息
N Engl J Med. 2021 Feb 18;384(7):682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27.
PMID:33503339
Abstract
摘要
相似文献
1
The Covid-19 Vaccine-Development Multiverse. Reply.
N Engl J Med. 2021 Feb 18;384(7):682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27.
2
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2021 Feb 18;384(7):681-682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27.
3
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2020 Nov 12;383(20):1986-1988. doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med. 2021 Apr 22;384(16):1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
5
COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
Indian Pediatr. 2021 Feb 15;58(2):195.
6
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.
7
[Reply to "Defining priorities, the case of of COVID-19 vaccine"].
G Ital Cardiol (Rome). 2021 Jun;22(6):510-511. doi: 10.1714/3612.35937.
8
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
9
COVID-19 basics and vaccine development with a Canadian perspective.
Can J Microbiol. 2021 Feb;67(2):112-118. doi: 10.1139/cjm-2020-0421.
10
Mandatory Coronavirus Disease 2019 Vaccine for Children?-Reply.
JAMA Pediatr. 2021 May 1;175(5):534. doi: 10.1001/jamapediatrics.2020.6013.
Zotero 插件